| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 | Amoroso Michael President and CEO | Sale | -20,559 | -7.79%243,392 | $3.84 | $78,947 | View SEC filing | |
| 2026-02-19 | Kelly John Alexander Chief Financial Officer | Sale | -8,149 | -6.08%125,883 | $3.84 | $31,292 | View SEC filing | |
| 2026-02-19 | Scimeca Dario General Counsel and Secretary | Sale | -4,925 | -8.02%56,457 | $3.84 | $18,912 | View SEC filing | |
| 2026-02-19 | SMITH J. JEFFERSON Chief Research Officer | Sale | -4,925 | -3.88%121,926 | $3.84 | $18,912 | View SEC filing | |
| 2026-01-22 | Amoroso Michael President and CEO | Sale | -34,799 | -15.07%196,154 | $4.17 | $145,112 | View SEC filing | |
| 2026-01-22 | Scimeca Dario General Counsel and Secretary | Sale | -8,854 | -16.53%44,715 | $4.03 | $35,682 | View SEC filing | |
| 2026-01-22 | Kelly John Alexander Chief Financial Officer | Sale | -15,213 | -12.50%106,448 | $4.03 | $61,308 | View SEC filing | |
| 2026-01-22 | SMITH J. JEFFERSON Chief Research Officer | Sale | -10,200 | -8.47%110,184 | $4.03 | $41,106 | View SEC filing | |
| 2025-12-17 | Germano Geno J Director | Purchase | +3,000 | +14.37%23,883 | $4.72 | $14,160 | View SEC filing | |
| 2025-12-17 | Frankel Stanley Director | Purchase | +2,700 | +16.09%19,478 | $4.70 | $12,690 | View SEC filing | |
| 2025-12-17 | Brown Melinda Director | Purchase | +1,381 | +6.29%23,346 | $4.97 | $6,864 | View SEC filing | |
| 2025-11-04 | Kelly John Alexander Chief Financial Officer | Sale | -1,303 | -1.66%77,298 | $6.49 | $8,456 | View SEC filing | |
| 2025-11-04 | Scimeca Dario General Counsel and Secretary | Sale | -665 | -2.30%28,258 | $6.49 | $4,316 | View SEC filing | |
| 2025-11-04 | Amoroso Michael President and CEO | Sale | -3,409 | -2.87%115,575 | $6.49 | $22,124 | View SEC filing | |
| 2025-09-30 | Frankel Stanley Director | Purchase | +2,700 | +19.18%16,778 | $4.97 | $13,419 | View SEC filing | |
| 2025-09-24 | Brown Melinda Director | Purchase | +1,400 | +6.81%21,965 | $4.89 | $6,846 | View SEC filing | |
| 2025-07-08 | Kelly John Alexander Chief Financial Officer | Sale | -14,827 | -16.79%73,485 | $4.26 | $63,163 | View SEC filing | |
| 2025-06-27 | Brown Melinda Director | Purchase | +1,682 | +8.91%20,565 | $4.14 | $6,963 | View SEC filing | |
| 2025-06-27 | Buehler Kevin Director | Purchase | +5,076 | +22.01%28,137 | $4.16 | $21,116 | View SEC filing | |
| 2025-03-28 | Brown Melinda Director | Purchase | +1,839 | +25.48%9,057 | $4.75 | $8,735 | View SEC filing | |
| 2025-03-28 | Buehler Kevin Director | Purchase | +4,523 | +51.92%13,235 | $4.67 | $21,122 | View SEC filing | |
| 2025-03-27 | Germano Geno J Director | Purchase | +3,250 | +41.63%11,057 | $5.30 | $17,225 | View SEC filing | |
| 2025-03-25 | Amoroso Michael President and CEO | Sale | -964 | -0.87%109,540 | $5.56 | $5,360 | View SEC filing | |
| 2025-03-05 | Scimeca Dario General Counsel and Secretary | Sale | -272 | -1.08%25,000 | $4.91 | $1,336 | View SEC filing | |
| 2025-03-05 | SMITH J. JEFFERSON Chief Research Officer | Sale | -154 | -0.18%87,805 | $4.91 | $756 | View SEC filing |
1-25 of 93
